UPMC Children’s Heart Institute ACHD Specialist, Anita Saraf, MD, PhD, Elected to AARCC Board of Directors

March 14, 2023

The Heart Institute at UPMC Children’s Hospital of Pittsburgh congratulates Anita P. Saraf, MD, PhD, on her election to the Board of Directors of The Alliance for Adult Research in Congenital Cardiology (AARCC).

Dr. Saraf is fellowship-trained in adult congenital heart disease (ACHD) and is a member of the UPMC Adult Congenital Heart Disease Program. Dr. Saraf holds dual academic appointments in the Department of Pediatrics and the Division of Cardiology in the Department of Internal Medicine at the University of Pittsburgh School of Medicine. In addition to her position in the Heart Institute at UPMC Children’s, she also is a member of the UPMC Heart and Vascular Institute.

Dr. Saraf’s clinical practice encompasses the full spectrum of ACHD, with a special focus on Fontan patients and women with adult congenital heart disease.

As a physician-scientist, Dr. Saraf studies the effect of complex NOTCH1 mutations in congenital heart disease on cardiomyocyte structure and function. Her work extends to developing translational models that may lead to new therapies for ACHD.

Dr. Saraf most recently was a co-author of a study conducted at UPMC Children’s on “Thromboprophylaxis in Patients With Fontan Circulation” published in January in the Journal of the American College of Cardiology.  (read article about this study on UPMCPhysicianResources.com).

More About the AARCC

AARCC was specifically formed with the goal of establishing a vivacious network of ACHD centers in North America for the purposes of proposing, funding, and carrying out such research.  AARCC exists as a research group to foster collaborative relationships between programs and investigators, to further and sustain research efforts, to include the goals of innovative investigations; advancing knowledge; and improving outcomes in Adult Congenital Heart Disease. Learn more about the organization here.